Pennsylvania state health officials report nearly 20% of people infected with measles have required hospital care.
RT’s Three Key Takeaways:
- Rising Mortality and Case Counts: The Pennsylvania Department of Health has confirmed the commonwealth’s fifth measles-associated death in an unvaccinated individual, with cumulative statewide cases reaching 943 across 39 counties in 2026.
- High Hospitalization Burden: Nearly 20% of individuals diagnosed with measles in the state have required acute inpatient hospitalization for complications that include pneumonia and brain swelling.
- Surge in Protective Immunizations: State healthcare clinicians administered more than 53,000 doses of the measles, mumps, and rubella vaccine in September, more than doubling typical monthly totals to curb transmission.
The Pennsylvania Department of Health (DOH) has reported the state’s fifth measles-associated death in an unvaccinated resident of Lancaster County who tested positive for measles and died.
Statewide confirmed cases have reached 943 across 39 counties, according to the DOH, which noted that 40 new positive cases were identified over a 2-day period, reflecting sustained transmission since the outbreak began in late April.
Respiratory Severity and Hospitalizations
For respiratory therapists and inpatient acute-care teams, the clinical trajectory of measles presents significant management concerns. According to the DOH, measles is a highly contagious respiratory virus that can produce serious acute and long-term health complications, notably pneumonia and encephalitis.
State tracking reveals that 176 individuals have required hospitalization, which represents nearly 20% of all confirmed patients. Overall mortality from the virus typically ranges between one to three deaths per 1,000 cases, according to state public health data.
The DOH highlighted that measles is transmitted through aerosolized respiratory droplets when an infected person breathes, coughs, or sneezes. The pathogen remains infectious suspended in the air and on environmental surfaces for up to 2 hours after an infected person vacates the room, requiring vigilant airborne infection isolation procedures across hospital and emergency settings. Symptoms typically begin 7 to 21 days following exposure and include fever, cough, coryza, and conjunctivitis, followed by a maculopapular rash that originates on the face and spreads downward. Patients are contagious from 4 days before through 4 days after the onset of rash.
Vaccine Efficacy and Clinical Response
Public health data continue to emphasize that vaccination provides strong protection against severe disease and inpatient admission. According to the DOH, only four confirmed infections during the outbreak occurred among vaccinated persons, representing less than 1% of total cases. The standard 2-dose series of the measles, mumps, and rubella (MMR) vaccine delivers 97% lifetime protection against infection.
In response to the rising case volume, Pennsylvania healthcare clinicians have seen elevated patient interest in immunization. In an average month, providers across the state administer approximately 25,000 MMR doses. That figure climbed to more than 49,000 doses in August and exceeded 53,000 doses in September.
Additionally, state health center staff have administered more than 5,500 MMR vaccines across 180 mobile community clinics since April, with department nurses delivering more than 8,500 total doses when combined with permanent state clinics to stem broader community spread.
